Navigation Links
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Date:11/19/2007

PRINCETON, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Novo Nordisk Inc. announced today that it has signed an exclusive agreement with Sciele Pharma, Inc. to market Prandin(R) (repaglinide). Under the terms of the agreement, Sciele will exclusively market Prandin(R) and, upon approval by the US Food and Drug Administration, PrandiMet(R) (the name submitted to FDA for a repaglinide/metformin fixed dose combination tablet) to physicians in the U.S., and will have a right of first refusal to obtain marketing rights in the U.S. to other Novo Nordisk products containing repaglinide, the active pharmaceutical ingredient in both Prandin(R) and PrandiMet(R).

"This partnership in the U.S. will enable us to increase the oral treatment options for people with type 2 diabetes to help them gain good glycemic control," said Martin Soeters, president of Novo Nordisk Inc. "It will also allow Novo Nordisk to concentrate on bringing our complete portfolio of three insulin analogs to health care providers, which provides the most viable opportunity to both help improve patient outcomes and realize our business aspirations, in the name of Changing Diabetes(R)."

Patrick Fourteau, president and CEO of Sciele Pharma, Inc., added, "We are pleased to initiate this partnership with Novo Nordisk, a company that is widely recognized as a global leader in diabetes care. Prandin(R) fits well within our Diabetes product portfolio and will be an excellent complement to Fortamet(R). Promoted by our Primary Care sales force, Prandin(R) will strengthen our presence in the diabetes treatment market."

About Prandin(R)

Prandin(R) is an oral blood glucose-lowering drug of the meglitinide class used in the management of type 2 diabetes mellitus. PrandiMet(R) is a combination tablet of repaglinide and metformin, which has yet to be approved by the FDA.

Prandin(R) is indicated as an adjunct to diet and exercise for patients with type 2 diabetes whose hyperglycemia cannot be
'/>"/>

SOURCE Novo Nordisk Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
2. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... NORTH HOLLYWOOD, Calif. , June 3, 2015 /PRNewswire/ ... quality of life of myeloma patients while working toward ... th Annual International Myeloma Working Group (IMWG) Summit ... A record 100-plus IMWG members will attend the 2015 ... Congress of the European Hematology Association (EHA).  The focus ...
(Date:6/3/2015)... June 03, 2015 On April 21, 2015, ... Utilities and Communications Committee (11-0) and indicates the legislature's desire ... renewable energy. , The Committee Chairman supports the bill and ... CAP by 8,000 GWh and would also like to see ... , This “Wait List” and timing are extremely important. ...
(Date:6/3/2015)... and CHICAGO , June 3, ... or "the Company"; LSE: CIR), a specialty biopharmaceutical company ... data relating to the Company,s novel immunotherapy candidates targeting ... presented at the 2015 European Academy of Allergy and ... Barcelona, Spain on 6-10 June. ...
(Date:6/3/2015)... June 03, 2015 Innovative biomass supply ... announced its platinum sponsorship of the first annual ... the Royal Sonesta Hotel in New Orleans, June 9-10, ... in an effort to further the advancements of feedstock ... and policies, overall logistics, yield improvement and more. ...
Breaking Biology Technology:International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 2International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 3International Myeloma Foundation Brings Together 100 of the World's Top Myeloma Experts June 8-10 in Vienna, Austria for 6th Annual Summit 4Bmark Energy Announces the Sign-up Deadline for Companies Interested in California’s Direct Access Program is June 12th, 2015 at 5:00pm. 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 2Genera to Sponsor Advanced Bioeconomy Feedstocks Conference 2015 3
... (Nasdaq: SGMO ) announced today that Edward ... on Sangamo,s diabetic neuropathy,programs at 1:40 p.m. (ET) ... Adams,Diabetes and Obesity Conference in San Francisco., ... be accessed via a link on,the Sangamo BioSciences ...
... Mass., May 29 Haemonetics,Corporation and Octapharma ... multi-year,supply contract appointing Haemonetics as Octapharma,s preferred ... States. Under the agreement,Octapharma will use Haemonetics, ... its U.S. plasma collection centers. Plasma is ...
... BALTIMORE, May 29 FASgen Diagnostics, LLC ... they have entered into,a collaboration to produce ... biomarkers,using FASgen,s proprietary antibodies. The tests measure ... (FAS), which is found in,virtually all solid ...
Cached Biology Technology:Sangamo BioSciences to Present at the Canaccord Adams Diabetes and Obesity Conference 2Haemonetics and Octapharma AG Announce Plasma Collection Technology Contract 2FASgen Diagnostics, LLC Announces Production and Investment Agreement With Tetracore, Inc. 2
(Date:5/11/2015)...  Through a well-rounded UAS delegation representing private industry, government, ... showing at AUVSI,s Unmanned 2015 conference last week in ... UAS industry met with over 200 hundred people ... the UAS ecosystem. "Our message is clear ... Aerospace Rich Knoll . "If you want to fly ...
(Date:5/8/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... of the executive management team will present at the following ... and Telecom Conference Date: May 18, 2015 Time: ... MA Cowen and Company Technology, Media ... Location: The New York Palace Hotel, New York, ...
(Date:5/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, reminds investors and media that  Mr. David ... CARTES SECURE CONNEXIONS AMERICA 2015, held in Washington ... three-day conference is organized into a series of nine session ... Global Fraud: Where is the Trust in Cyberspace? and ...
Breaking Biology News(10 mins):Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Synaptics to Present at Upcoming Investor Conferences 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3
... CLEVELANDTwo teams of researchers, including a scientist from Case ... new species of fossil horse from 4.4 million-year-old fossil-rich ... the size of a small zebra, Eurygnathohippus woldegabrieli ... at Case Western Reserve in 1987had three-toed hooves and ...
... is available in German . ... have been announced. On Thursday, 5 December 2013, the Joint Committee ... ,four women and seven men as winners of the ... the Nominations Committee from 129 nominees. Four of the eleven prizewinners ...
... study shows that two unusual treatment approaches may have beneficial ... with the disorder. Using a hot bath to raise body ... worm eggs to stimulate the production of immunoregulatory factors in ... autism. These findings support the idea that disruption of systems ...
Cached Biology News:A new species of horse, 4.4 million years old 2A new species of horse, 4.4 million years old 3Leibniz Prizes 2014: DFG honors 11 outstanding researchers 2Leibniz Prizes 2014: DFG honors 11 outstanding researchers 3Leibniz Prizes 2014: DFG honors 11 outstanding researchers 4Leibniz Prizes 2014: DFG honors 11 outstanding researchers 5Leibniz Prizes 2014: DFG honors 11 outstanding researchers 6Leibniz Prizes 2014: DFG honors 11 outstanding researchers 7Leibniz Prizes 2014: DFG honors 11 outstanding researchers 8Leibniz Prizes 2014: DFG honors 11 outstanding researchers 9Leibniz Prizes 2014: DFG honors 11 outstanding researchers 10Leibniz Prizes 2014: DFG honors 11 outstanding researchers 11Leibniz Prizes 2014: DFG honors 11 outstanding researchers 12Leibniz Prizes 2014: DFG honors 11 outstanding researchers 13Worms and hot baths: Novel approaches to treating autism 2
The Holten Horizontal series of laminar airflow work benches offers comfort and ease of use....
... Angle Polypropylene Rotor designed for use ... CL3/CL3R** and Centra-MP4/MP4R*. A translucent lid ... ,EXCLUSIVE polypropylene rotor design provides excellent ... autoclaved. Polypropylene rotors are fully ...
Medium bottle for hybridization 250 x 35mm...
Extra Large bottle for hybridization 300 x 70mm...
Biology Products: